Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Variants inside and outside of target region - what's the difference?

    Hello:

    I am trying to understand whether there is some drastic difference between on-target and off-target reads. I assume that even if there is a true variant outside of target region, it is not of interest anyway. Apart from that, is there any difference between the two sets of reads and the variants detected by such reads?

    In terms of (quantitative) metrics that can be computed for VCF files, is there any difference between the variants inside and outside of target region? For instance, if I were to compute an average depth across variants inside the target region, will it be higher than the depth outside the target region?

    Thanks in advance,
    Nik

  • #2
    I assume you are talking about exome-capture?

    There is no important difference between on- and off-target reads. Variants outside target regions may be of interest, though it's less likely; and of course 99.99% of variants inside the target are of no interest, but presumably they will tend to be more interesting than the ones outside the targets. Note that the gene annotations are continuously evolving as new genes and isoforms are discovered, while baits for capture kits may be based on annotation from many years earlier.

    If the capture was successful, then yes, the coverage will be much higher within the targets than outside.

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      09-09-2024, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, Today, 06:25 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, Yesterday, 01:02 PM
    0 responses
    12 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-18-2024, 06:39 AM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-11-2024, 02:44 PM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Working...
    X